Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....

TRANSGENE BIOTEK LIMITED INNOVATING. FOR LIFE. July 22, 2026 The General Manager Department of Corporate Services, BSE Ltd., Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001 Scrip Code: 526139 Respected Sir /M adam, Subject: Intim ation of the Board Meeting. Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby infom you that a meeting of the Board of Directors of Transgene Biotek Limited is scheduled to be held on Friday, August 07, 2026, inter alia, to consider and approve the following matters: 1. To consider and approve the n-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2026. 2. To consider and approve the Limited Review Report (Standalone & Consolidated) of the Company for the quarter ended 30h June 2026. 3. To consider and approve seeking an extension of time for holding the Annual General Meeting (AGM) of the Company for the Financial Year 2025-26. 4. Toc onsider and approve the appointment of the internal auditor of the Company for financial year 2026-27. 5. To transact such other business as may be required. Further, we wish to infom you that as per the Code of Conduct adopted by the Company, to regulate. monitor and report trading by insiders, pursuant to the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the Trading Window for dealing in the securities of the Company was already closed from 1" July, 2026 till 48 hours after the financial results of the Company for the quarter ended on 30 June, 2026 and becomes a generally available infomation. This is for your information and records. Thanking you Yours Sincerely For TRANSGENE BIOTEK LIMITED DR. K. KOTESWARAR AO CHAIRMAN & MANAGING DIRECTOR Plot 69 & 70, IDA Bollaram, Sangareddy District – 502 325, Telangana, India Ph: +91-8458-279744 Web: www.transgenebiotek.com Email: info@transgenebiotek.com, CIN No: L85195AP1990PLCO11065